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Heat shock protein A12B (HSPA12B) is predominately expressed in endothelial cells
(ECs) and has been reported to protect against cardiac dysfunction from endotoxemia
or myocardial infarction. This study investigated the mechanisms by which endothelial
HSPA12B protects polymicrobial sepsis–induced cardiomyopathy. Wild-type (WT) and
endothelial HSPA12B knockout (HSPA12B−/− ) mice were subjected to polymicrobial
sepsis induced by cecal ligation and puncture (CLP). Cecal ligation and puncture sepsis
accelerated mortality and caused severe cardiac dysfunction in HSPA12B−/− mice
compared with WT septic mice. The levels of adhesion molecules and the infiltrated
immune cells in the myocardium of HSPA12B−/− septic mice were markedly greater
than in WT septic mice. The levels of microRNA-126 (miR-126), which targets adhesion
molecules, in serum exosomes from HSPA12B−/− septic mice were significantly lower
than in WT septic mice. Transfection of ECs with adenovirus expressing HSPA12B
significantly increased miR-126 levels. Increased miR-126 levels in ECs prevented LPSstimulated expression of adhesion molecules. In vivo delivery of miR-126 carried by
exosomes into the myocardium of HSPA12B−/− mice significantly attenuated CLP
sepsis increased levels of adhesion molecules, and improved CLP sepsis–induced
cardiac dysfunction. The data suggest that HSPA12B protects against sepsis-induced
severe cardiomyopathy via regulating miR-126 expression which targets adhesion
molecules, thus decreasing the accumulation of immune cells in the myocardium.
Keywords: endothelial HSPA12B, polymicrobial sepsis, cardiomyopathy, exosomes, microRNAs, endothelial
adhesion molecules

INTRODUCTION
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host innate
and inflammatory responses to the infection (1). In the United States, the mortality rates of
sepsis is 28.3%, which is higher than other disease in intensive care units (2). Cardiovascular
dysfunction is a major complication associated with sepsis-induced morbidity and mortality [7;9].
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Cardiomyopathy is present in >40% of sepsis patients (3, 4) and
is associated with mortality rates of up to 70% (3, 4). Despite the
severity of this condition, the mechanisms that mediate septic
cardiomyopathy remain unclear.
Endothelial cell (EC) dysfunction contributes to multiple
organ damage and high morbidity and mortality in sepsis/septic
shock (5). Increasing evidence shows that ECs actively
participate in both innate and adaptive immune responses
(6, 7) via pattern recognition receptors, including Tolllike receptors (8). Pathogen-associated molecular patterns,
such as LPS or endogenous ligands, generated during
sepsis/septic shock stimulate EC activation. Activated
ECs have upregulated expression of chemokines and
adhesion molecules, which attract and promote immune
cell infiltration and inflammatory response, resulting in
organ injury (9). Therefore, preservation of endothelial
function is an important approach for attenuating
sepsis-induced outcomes.
HSPA12B is the newest member of the HSP70 family
of proteins (10). It is predominantly expressed in ECs (11,
12) and is essential for angiogenesis (12). Stegall et al.
have demonstrated that endothelial HSPA12B is involved in
angiogenesis through the turnover of a known angiogenesis
regulator, a kinase anchoring protein 12 (AKAP12), resulting
in upregulation of VEGF expression (12). Hu et al. (11)
reported the endothelial HSPA12B is involved in regulating
EC function. Knockdown of HSPA12B by small interfering
RNAs in human umbilical vein ECs (HUVECs) interfered
with wound healing, EC migration, and tube formation. In
contrast, overexpression of HSPA12B enhanced migration of
ECs and accelerated wound healing (11). We have reported
that transgenic mice overexpressing HSPA12B (HSPA12B Tg)
exhibit protection against myocardial ischemic injury and
attenuate LPS-induced cardiac dysfunction (13). HSPA12B has
been reported to preserve EC function (14, 15). However, the
mechanisms by which HSPA12B preserves EC function during
sepsis are still unknown.
MicroRNAs (miRs) have been identified as novel regulators
of gene expression at the posttranscriptional level by binding
to target messenger RNAs (16, 17). Recent evidence suggests
that miRs play a critical role in sepsis/septic shock–induced
innate immune and inflammatory responses (16, 17). MicroRNA126 (miR-126) is predominantly expressed in ECs (18) and
has been reported to regulate the progression of angiogenesis
(19) and the expression of vascular cell adhesion molecule 1
(VCAM-1) (20). MicroRNA-126 is also involved in regulation
of survival and function of plasmacytoid dendritic cells via the
VEGFR2 pathway (21), indicating that miR-126 may regulate
innate immune responses. However, the role of miR-126 in
sepsis-induced cardiomyopathy has not been investigated.
The present study has shown that endothelial-specific
HSPA12B exerts a protective effect on sepsis-induced
cardiomyopathy. We demonstrated that EC HSPA12B
could regulate miR-126 expression, which targets adhesion
molecules, resulting in decreases in the accumulation of immune
cells in the myocardium, thus attenuating sepsis-induced
cardiac dysfunction.
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MATERIALS AND METHODS
Animals
Male C57BL/6 mice were obtained from Jackson Laboratory.
Endothelial cell–specific HSPA12B knockout (HSPA12B−/− )
mice were generated as described below. Wild-type (WT)
and HSPA12B−/− mice were maintained in the Division of
Laboratory Animal Resources, East Tennessee State University
(ETSU). The experiments outlined in this article conform to the
Guide for the Care and Use of Laboratory Animals published
by the National Institutes of Health (NIH Publication, eighth
edition, 2011). The animal care and experimental protocols were
approved by the ETSU Committee on Animal Care.

Generation of EC-Specific HSPA12B
Knockout Mice
The knockout targeting strategy is outlined in Supplementary
Figure S1. LoxP sites flanking exon 2 were introduced using
a recombineering-based approach for making linearized
targeting construct. The targeting construct contained PGKdriven Neo cassette and MC1 promoter–driven HSV-TK
cassette, allowing for positive and negative selection. The right
and the left arm loxP knockin were confirmed by genomic
Southern blot with (EcoRI and probe A) and Sall digestion
of polymerase chain reaction (PCR) product by external
and internal primer (50 -TCTGTGTCTGCCTGTGTTCTGT
and 50 -TAGTCTGCATTCGGAGGCAAGT). The successful
homologous recombination clones were subsequently transfected
with pCre-Pac for excision by Cre to generate targeted alleles.
Endothelial-specific HSPA12B knockout mice were generated
by cross-breeding the conditionally targeted HSPA12B mice
with C57BL/6.Cg-Tg (Tek-cre) strain, which carries Cre
recombinase under the control of the Tek promoter. Genotypes
for the specific deletions were confirmed by PCR analysis of
floxed allele (HspA12B-cko-1: gaagcaagcatattcatctcattactattc;
HspA12B-cko-2: gcttgctcaaaagtgatggttgctc. 151 bp for
knockout and 191 bp for WT mice), HSPA12B deletion
(HspA12B-cko-1: gaagcaagcatattcatctcattactattc; HspA12Bcko-4: taaagcctacactcagatgagagcag, 240-bp product for deletion
and > 2 kB or no product for WT control), and for Cre
gene expression. Western blot and immunohistochemistry
were also performed to identify endothelial-specific
deficiency of HSPA12B.

Immunofluorescence Staining
Immunohistochemistry was performed as described previously
(22, 23). Briefly, the heart sections were stained with primary
antibodies that are specific rabbit anti-HSPA12B and rat antiCD31 (PECAM-1) (1:100) overnight at 4◦ C. The tissue sections
were then incubated with secondary antibody Alexa Fluor-488
goat anti-rabbit immunoglobulin G (IgG) (H + L) (green;
Thermo Fisher Scientific, Waltham, MA, United States) and
Alexa Fluor-555 goat anti-rat IgG (H + L) (red) (Thermo Fisher
Scientific) for 1 h at room temperature. The slides were examined
with a fluorescent microscope at a magnification of 40×.
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Electrophoretic Mobility Shift Assay

Cecal Ligation and Puncture
Polymicrobial Sepsis Model

Nuclear proteins were isolated from heart samples as previously
described (22, 23). Nuclear factor κB (NF-κB) binding activity
was performed using a LightShift Chemiluminescent EMSA
(electrophoretic mobility shift assay) kit (Thermo Fisher
Scientific) as described previously (22, 25) in a 20-µL binding
reaction mixture containing 1× binding buffer, 50 ng poly dI:dC,
20 fmol of double-stranded NF-κB consensus oligonucleotide
that was end-labeled with biotin, 15 µg nuclear proteins. The
binding reaction mixture was incubated at room temperature for
20 min and analyzed by electrophoresis and then transferred to
a nylon membrane. The biotin end-labeled DNA was detected
using the streptavidin–horseradish peroxidase conjugate and the
chemiluminescent substrate (22, 25).

Cecal ligation and puncture (CLP) was performed to induce
polymicrobial sepsis in mice as previously described (22, 23).
Briefly, the mice were anesthetized by isoflurane (induced by
5.0% and maintained by 1.5%). A midline incision was made on
the anterior abdomen, and the cecum was exposed and ligated
with a 4-0 suture. Two punctures were made through the cecum
with an 18-gauge needle, and feces were extruded from the holes.
The abdomen was then closed in two layers. Sham surgically
operated mice served as the surgery control group. Immediately
following surgery, a single dose of resuscitative fluid (lactated
Ringer’s solution, 50 mL/kg body weight) was administered by
subcutaneous injection (22, 23).

Enzyme-Linked Immunosorbent Assay
for Cytokine Assay

Echocardiography
Transthoracic two-dimensional M-mode echocardiogram was
obtained using a Toshiba Aplio 80 Imaging System (Toshiba
Medical Systems, Tochigi, Japan) equipped with a 12-MHz linear
transducer as described previously (22). M-mode tracings were
used to measure LV end-systolic diameter and LV end-diastolic
diameter. Percent fractional shortening (% FS) and ejection
fraction (EF %) were calculated as described previously (22, 24).

The levels of cytokines [tumor necrosis factor α (TNFα),
interleukin 6 (IL-6)] in cell-free supernatants were measured
by enzyme-linked immunosorbent assay development kits
(Peprotech, Rocky Hill, NJ, United States) according to
manufacturers’ instructions as described previously (22, 23).

Western Blot

Accumulation of Neutrophils and
Macrophages in the Myocardium

Western blot was performed as described previously (22, 23).
Briefly, the cellular proteins were separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and transferred onto
Hybond ECL membranes (Amersham Pharmacia, Piscataway,
NJ, United States). The ECL membranes were incubated with
the appropriate primary antibodies (anti–VCAM-1 and anti–
ICAM1 from Santa Cruz Biotechnology; anti-CD63, anti-CD81,
from System Biosciences, Palo Alto, CA, United States; antiGAPDH from Meridian Life Science, Inc., Memphis, TN,
United States, respectively. Anti-HspA12B is a kind gift from
Dr. Han Zhihua) followed by incubation with peroxidaseconjugated secondary antibodies (Cell Signaling Technology,
Inc., Danvers, MA, United States) and analysis by the ECL system
(Amersham Pharmacia). The signals were quantified using the
G: Box gel imaging system by Syngene (Syngene, USA, Fredrick,
MD, United States).

Accumulation of immune cells in heart tissues was examined with
antineutrophil elastase antibody (Abcam, Cambridge, United
Kingdom) and antimacrophage antibody F4/80 (1:50 dilution;
Santa Cruz Biotechnology, Santa Cruz, CA, United States),
separately (22, 23). Three samples from each group were
evaluated, counterstained with hematoxylin, and examined with
bright-field microscopy. Four different areas of each section
were evaluated. The results are expressed as the numbers of
neutrophils or macrophages per field examined with bright field
microscope (40×).

Myeloperoxidase Activity Assay
Myeloperoxidase (MPO) activity was measured using an MPO
fluorometric Detection kit (Assay Designs Inc., Ann Arbor, MI,
United States) according to the manufacturers’ instructions.

Isolation of Exosomes
Ten hours after CLP, the blood was collected from the
experimental mice followed by centrifugation at 5,400
revolutions/min (rpm) for 15 min at 18◦ C. The supernatant
was collected and added with ExoQuick exosome precipitation
solution (63 µL/250 µL plasma, ExoQ5A-1; SBI, Palo Alto, CA,
United states) according to manufacturer’s instruction.

Immunohistochemistry Staining
Immunohistochemistry was performed as described previously
(22, 23). Briefly, heart tissues were immersion-fixed in 4%
buffered paraformaldehyde, embedded in paraffin, and cut at
5-µm sections. The sections were stained with specific goat antiintercellular adhesion molecule 1 (ICAM-1, 1:50 dilution; Santa
Cruz Biotechnology) and rabbit anti-VCAM-1 (1:50 dilution,
Santa Cruz Biotechnology), respectively, and treated with the
ABC staining system (Santa Cruz Biotechnology) according to
the instructions of the manufacturer. Three slides from each
block were evaluated, counterstained with hematoxylin, and
examined with bright field microscope (40×). Four different
areas of each section were evaluated.
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Isolation of RNA From Exosomes
Total RNA was extracted from the exosomes using Trizol
(RN190; Molecular Research Center, Cincinnati, OH,
United States) according to manufacturer’s instructions.
Approximately 10 ng of total RNA was applied to examination of
miRNA levels as described previously (26).
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In vivo Delivery of Exosomal miR-126
Into Mouse Hearts

Quantitative PCR Assay of MiRNAs
MicroRNAs were isolated from heart tissues or exosomes using
the mirVana miR isolation kit (Ambion, Austin, TX, United
States) as described previously (27). MicroRNA levels were
quantified by quantitative PCR (qPCR) using specific Taqman
assays (Applied Biosystems, Foster City, CA, United States)
and specific primers (Applied Biosystems, primer identification
numbers: 002228 for hsa–miR-126-3p and 001973 for snRU6).
The levels of miRs were quantified with the 2(− 11ct) relative
quantification method that was normalized to the U6 small
nucleolar RNA (snRU6).

Mice were transfected with exosomes loaded with miR-126 or
exosomes loaded with miR-control through the right carotid
artery as described previously (27, 29). Briefly, mice were
intubated and mechanically ventilated. The anesthesia was
induced by 5% isoflurane and maintained by 1.5% isoflurane
driven by 100% oxygen. Body temperature was maintained at
37◦ C by surface water heating. An incision was made in the
middle of the neck, and the right common carotid artery was
carefully exposed. A microcatheter was introduced into the
isolated common carotid artery and positioned into the aortic
root. Exosomes (10 µg diluted in 100 µL PBS) loaded with
miR-126 or loaded with miR-Con were injected through the
microcatheter immediately after the induction of polymicrobial
sepsis. The microcatheter was gently removed, and the common
carotid artery was tightened before the skin was closed (22, 23).

Treatment of ECs With Exosomes
Exosomes were isolated from sham and septic mice using
ExoQuickTC exosome precipitation solution (ExoQ5A-1; SBI).
Human umbilical vein ECs were treated with exosomes
(5 µg/mL) diluted in conditional medium, which was exosomefree medium prepared by centrifugation at 120,000 rpm for 18 h
at 4◦ C. After treatment, HUVECs were collected for analysis
of adhesion molecules ICAM-1 and VCAM-1 by Western
blot (22, 23).

Statistical Analysis
The data are expressed as mean ± SE. Comparisons of data
between groups were made using one-way analysis of variance,
and Tukey procedure for multiple-range tests was performed.
The log-rank test was used to compare group survival trends.
Probability levels of 0.05 or smaller were used to indicate
statistical significance.

Transfection of MiRNA Mimics Into ECs
Human umbilical vein ECs (1 × 106 ) in six-well plates were
transfected with 40 nmol of miR-126 mimics (Ambion), anti–
miR-126 mimics (Exiqon) and miR-scrambled control (Exiqon),
respectively by Lipofectamine 2000 (Thermo Fisher Scientific).
Twenty-four hours after transfection, the cells were treated
with LPS (1 µg/mL) for 24 h. The cells were harvested
for analysis of adhesion molecules (VCAM-1 and ICAM-1)
by Western blot.

RESULTS
EC-Specific Deficiency of HSPA12B
(HSPA12B−/− ) Results in Increased
Mortality in Polymicrobial Sepsis

Preparation of Exosomal miR-126

We first examined the expression of HSPA12B in the
myocardium. As shown in Figure 1A, HSPA12B is
specifically expressed on cardiac ECs as evidenced by positive
immunofluorescent staining of HSPA12B on ECs in the
myocardium from WT mice but not from HSPA12B−/−
mice. Western blot analysis shows the high levels of myocardial
HSPA12B in WT mice but not in HSPA12B−/− mice (Figure 1B).
Figure 1C shows that EC HSPA12B deficiency accelerates
mortality of CLP septic mice. The time to 50% mortality in WT
septic mice was 56 h, and 100% occurred at 100 h after induction
of CLP-sepsis. In HSPA12B−/− septic mice, however, the time to
50% mortality was 40 h. The mortality reached to 100% was 60 h
after induction of CLP sepsis (P < 0.01). These data indicate that
EC HSPA12B plays a role in reducing the mortality associated
with polymicrobial sepsis.

Bone marrow stromal cells (BMSCs) were isolated from
HSPA12B−/− and WT mice as described previously (28).
Briefly, mice were euthanized, and bone marrow was isolated
by flushing the femur and tibia with Dulbecco modified Eagle
medium (DMEM) using a 25-gauge 0.5-inch needle (BD, San
Jose, CA, United States). The bone marrow was dissociated by
syringe. Cell mixture was cultured in DMEM supplemented
with 10% fetal bovine serum (FBS) (HyClone; Thermo Fisher
Scientific), glutamine (2 mM), and penicillin/streptomycin (50
U/mL and 50 mg/mL; Sigma-Aldrich, St. Louis, MO, United
States). After incubation at 37◦ C with 5% CO2 , non-adherent
cells were removed carefully by two washes with phosphatebuffered saline (PBS), and fresh medium was replaced. The
medium was changed every other day. Cells at the fourth
to seventh generation were transfected with 40 nmol/L hsa–
miR-126 mimics (MC12841; Ambion), hsa–miR-126 inhibitor
(MH12841; Ambion), or Cy3 dye–labeled miR-scrambled
control (AM17010; Ambion), using Lipofectamine 2000
transfection reagent (Thermo Fisher Scientific) according to the
manufacturer’s protocol. Twenty-four hours after transfection,
supernatants were harvested for exosome isolation using
Exoquick-TC Exosome Precipitation Solution (SBI) according to
the manufacturer’s protocol.

Frontiers in Immunology | www.frontiersin.org

Endothelial HSPA12B Deficiency Results
in Worsened Cardiac Dysfunction in
Polymicrobial Sepsis
Cardiomyopathy is a major consequence of sepsis and
contributes to mobility and mortality (30). Figures 1D,E
show that CLP sepsis markedly decreased the values of
EF% (34.3%) and % FS (42.8%) in WT septic mice and 48.2
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FIGURE 1 | Endothelial-specific deficiency of HSPA12B results in increased mortality and worsened cardiac dysfunction in polymicrobial sepsis. (A,B) HSPA12B is
expressed in the ECs of WT myocardium but not in HSPA12B−/− mice. (A) Heart tissues from WT and HSPA12B−/− mice were sectioned and subjected to
immunostaining with anti-CD31 (EC marker) and anti-HSPA12B. There is a negative staining of HSPA12B in the myocardium of HSPA12B−/− mice. The
immunofluorescent staining was examined with fluorescent microscope (40×). (B) Western blot analysis of HSPA12B expression in the myocardium of WT and
HSPA12B−/− mice. (C) Sepsis increases the mortality of HSPA12B−/− mice. Wild-type and HSPA12B−/− mice were subjected to CLP sepsis. Sham surgical
operation served as sham control. The survival rate was closely monitored up to 5 days (n = 15–16/group). (D,E) Cardiac function was examined by
echocardiography before and 6 h after CLP (n = 6–13/group). Cecal ligation and puncture sepsis markedly decreases ejection fraction (EF %) and fractional
shortening (FS %) in WT mice. However, the values of EF % and FS % in HSPA12B−/− septic mice were further decreased compared with WT septic mice. (D) (EF
%) and (E) (FS %). *P < 0.05 compared with indicated group.
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and 56.5% in HSPA12B−/− septic mice, when compared
with the respective sham controls. HSPA12B−/− septic
mice exhibited a lower EF% (20.5%) and FS% (22.8%) than
in WT septic mice. There was no significant difference
in the baseline values of EF% and %FS between WT and
HSPA12B−/− mice. These data indicate that EC HSPA12B plays
an important role in the regulation of cardiac function during
polymicrobial sepsis.

Figures 2F,G show that CLP sepsis increased the immunostaining
of VCAM-1 (F) and ICAM-1 (G) in the myocardium of WT
mice. However, there is more positive immunostaining for
VCAM-1 and ICAM-1 in the myocardium from HSPA12B−/−
septic mice than in WT septic mice. Western blot analysis
shows that CLP sepsis markedly increased the levels of
myocardial VCAM-1 (Figure 2H) and ICAM-1 (Figure 2I) in
WT mice. The levels of myocardial VCAM-1 and ICAM-1 in
HSPA12B−/− septic mice were further increased 173 and 191%,
respectively, when compared with WT septic mice. The data
suggest that HSPA12B is involved in the regulation of adhesion
molecule expression on ECs, which ultimately facilitate the
infiltration of inflammatory cells into the myocardium following
polymicrobial sepsis.

Inflammatory Cells Are Increased in the
Myocardium of HSPA12B−/− Septic Mice
Increased accumulation of inflammatory cells, including
neutrophils and macrophages, in the myocardium contributes
to septic cardiomyopathy (22). Figure 2A shows that CLP
sepsis markedly increased the numbers of neutrophils
(9.3 ± 0.66 vs. 1.8 ± 0.22) and MPO activity (89.9%) in
the myocardium of WT mice, when compared with WT
sham controls. In contrast, neutrophil accumulation in the
myocardium and myocardial MPO activity in HSPA12B−/−
septic mice was significantly 72 and 88% greater than
in WT septic mice. Cecal ligation and puncture sepsis
also significantly increased the numbers of macrophages
(15.6 ± 1.01 vs. 2.6 ± 0.0.36) in the myocardium of
WT mice compared with sham control (Figure 2B). In
HSPA12B−/− septic mice, macrophage accumulation in the
myocardium was markedly 57.9% higher than in WT septic
mice. The data indicate that EC HSPA12B could attenuate
infiltration of immune cells into the myocardium during
polymicrobial sepsis.

Increased HSPA12B Levels Suppress
LPS-Induced VCAM-1 and ICAM-1
Expression in ECs
To further investigate the role HSPA12B in the regulation
of adhesion molecule expression during polymicrobial
sepsis, we performed in vitro experiments. Endothelial cells
(HUVECs) were transfected with adenovirus expressing
HSPA12B (Ad-HSPA12B) or Ad-GFP (Figure 3A). Twentyfour hours after transfection, the cells were stimulated with
LPS (1 µg/mL) for 24 h. Confocal microscope examination
shows that LPS stimulation increased ICAM-1 expression
as evidenced by showing more immunofluorescent staining
of ICAM-1 in LPS-stimulated ECs (Figure 3B). Western
blot analysis also shows that LPS stimulation markedly
increased the expression of VCAM-1 (Figure 3C) and ICAM1 (Figure 3D), when compared with untreated control.
However, both immunostaining and Western blot analysis
show that increased HSPA12B expression by Ad-HSPA12B
transfection markedly suppressed LPS-stimulated expression
of VCAM-1 and ICAM-1. The data suggest that HSPA12B
may prevent upregulation of adhesion molecule expression in
ECs during sepsis.

Increased Myocardial NF-κB Activation
and Serum Inflammatory Cytokine Levels
in HSPA12B−/− Septic Mice
Nuclear factor κB is an important transcription factor
that regulates inflammatory cytokine production (31).
Proinflammatory cytokines have been demonstrated to play
a role in cardiovascular dysfunction during sepsis/septic
shock (32). Figure 2C shows that myocardial NF-κB
binding activity was markedly increased 36.8% in WT
septic mice and 82.3% in HSPA12B−/− septic mice, when
compared with the respective sham controls. Cecal ligation
and puncture sepsis also significantly increased the serum
levels of TNFα (Figure 2D) and IL-6 (Figure 2E) in WT
septic mice. However, the levels of serum TNFα and IL-6 in
HSPA12B− /− septic mice were markedly 243 and 223% greater
than in WT septic mice (Figures 2D,E). The data indicate
that EC HSPA12B plays a role in the regulation of NF-κB
activation and proinflammatory cytokine production during
polymicrobial sepsis.

HSPA12B Upregulates MiRNA-126
Expression in ECs
MicroRNA-126 is predominantly expressed in ECs and
suppresses adhesion molecule expression (18, 20). We
examined whether HSPA12B suppressed LPS-induced
adhesion molecule expression is mediated via upregulation
of miR-126 expression in ECs. We transfected HUVECs
with Ad-HSPA12B or Ad-GFP, which served as vector
control. Twenty-four hours after transfection, the cells
were stimulated with LPS. The levels of miR-126 were
measured by qPCR. As shown in Figure 4, LPS stimulation
increased the levels of miR-126 (A) and HSPA12B (B)
in ECs. Interestingly, LPS stimulation further increased
expression of miR-126 and HSPA12B after the cells were
transfected by Ad-HSPA12B. The data indicate that HSPA12B
is involved in the regulation of miR-126 expression in ECs
following LPS challenge.

HSPA12B−/− Results in Increased
Expression of Adhesion Molecules
Following Polymicrobial Sepsis
Increased expression of adhesion molecules on ECs promotes
the infiltration of inflammatory cells into the myocardium (33).
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FIGURE 2 | Continued
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FIGURE 2 | Increased accumulation of immune cells and NF-κB binding activity in the myocardium of HSPA12B−/− septic mice. Wild-type and HSPA12B−/− mice
were subjected to CLP sepsis or sham surgical operation. Heart tissues were harvested 6 h after CLP. (A) The accumulation of neutrophils in heart tissues was
examined by immunohistochemistry with antineutrophil antibody and MPO activity (n = 6–8/group). (B) Macrophages in the heart tissues were examined by
antimacrophage antibody F4/80. The positive staining of neutrophils and macrophages are dark brown color marked with red arrows. (C) Myocardial NF-κB binding
activity in WT and HSPA12B−/− septic mice was performed with EMSA (n = 6–8/group). (D,E) Serum cytokine TNFα (D) and IL-6 (E) levels were measured by
EMSA kits (n = 4–8/group). (F–I) Increased expression of adhesion molecules in the myocardium of WT and HSPA12B−/− septic mice. Heart tissues were harvested
6 h after CLP, sectioned, and subjected to immunohistochemistry staining with anti–VCAM-1 (F) and anti–ICAM-1 (G) antibodies. (H,I) Western blot analysis of
VCAM-1 (H) and ICAM1 (I) levels in the heart tissues. n = 4–8/group. *P < 0.05 compared with indicated groups. The immunohistochemistry staining was examined
with bright field microscope (40×).

alter LPS-stimulated increases in the expression of adhesion
molecules. The data suggest that miR-126 targets adhesion
molecule expression in ECs.

MiR-126 Suppresses LPS-Increased
Adhesion Molecule Expression in ECs
We then examined whether increased miR-126 levels will
suppress LPS-stimulated adhesion molecule expression in ECs.
We transfected ECs with miR-126 mimics or miR-control mimics
24 h before the cells were stimulated with LPS. Figure 4C shows a
high efficiency of the miRNA transfection into ECs. Transfection
of ECs with miR-126 mimics prevented LPS-stimulated the
expression of VCAM-1 (Figure 4D) and ICAM-1 (Figure 4E).
Antagomir-126 or miR-control mimics transfection did not
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Decreased Levels of miR-126 Levels in
Serum Exosomes From HSPA12B−/−
Septic Mice
To investigate whether increased adhesion molecule expression
in the myocardium from HSPA12B−/− septic mice will be
associated with miR-126 levels, we collected serum from WT
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FIGURE 3 | HSPA12B attenuates LPS-induced expression of adhesion molecules in ECs. Endothelial cells (HUVECs) were transfected with adenovirus-expressing
HSPA12B (Ad-HSPA12B) or Ad-GFP 24 h before the cells were stimulated with LPS. (A) Green color indicates Ad-HSPA12B transfected into the HUVECs. Western
blot shows that transfection of HUVECs with Ad-HSPA12B increased the levels of HSPA12B. (B) Confocal microscopy examination (66×) shows that Ad-HSPA12B
transfection attenuates LPS-induced ICAM-1 (red color) expression in HUVECs. Green color indicates HSPA12B; blue color indicates nucleus stained with DAPI.
(C,D) Western blot shows that Ad-HSPA12B transfection significantly suppressed LPS-induced VCAM-1 (C) and ICAM-1 (D) expression in HUVECs. n = 3/groups.
*P < 0.05; **P < 0.01; ***P < 0.001 compared with indicated groups.
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FIGURE 4 | Transfection of endothelial cells with miR-126 mimics prevented LPS-induced expression of adhesion molecule expression. Endothelial cells (HUVECs)
were transfected with 40 nmol of microRNAs (scrambled miR-control, miR-126 mimics, or anti–miR-126) by Lipofectamine 2000. Twenty-four hours after
transfection, the cells were treated with LPS (1 µg/mL) for 6 h. (A) miR-126 levels and (B) HSPA12B expression. (C) Transfection of miR-126 mimics (red color) into
endothelial cells. Transfection of miR-126 mimics suppresses LPS-induced expression of VCAM-1 (D) and ICAM1 (E) in endothelial cells. n = 3–4/group. *P < 0.05
compared with indicated groups.
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FIGURE 5 | Serum exosomes from HSPA12B−/− septic mice increased expression of adhesion molecules in endothelial cells. Wild-type and HSPA12B−/− mice
were subjected to CLP sepsis or sham surgical operation. Ten hours after CLP, blood was collected for the isolation of serum exosomes with ExoQuick exosome
isolation kit. (A) miR-126 levels in the isolated serum exosomes were examined by qPCR. (B) Exosome markers (CD63 and CD81). (C) Endothelial cells (HUVEC)
were treated with isolated exosomes for 12 h. The cells were harvested for analysis of VCAM-1 (C) and ICAM1 (D) by Western blot (n = 4–6/group). C, control; L,
LPS; WS, WT sham; WC, WT CLP; HS, HSPA12B−/− sham; HC, HSPA12B−/− CLP; Exo, exosomes. ∗ P < 0.05 compared with indicated groups.
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and HSPA12B−/− sham and septic mice, isolated exosomes, and
examined miR-126 levels with qPCR. As shown in Figure 5A,
CLP sepsis markedly increased the levels of miR-126 in exosomes
from WT mice but not from HSPA12B−/− mice. The levels
of miR-126 in HSPA12B−/− septic exosomes were significantly
lower than in WT septic exosomes. The data indicate that
lower levels of miR-126 in HSPA12B−/− septic exosomes may
be responsible for increased expression of adhesion molecules
and accumulation of immune cells in the myocardium of
HSPA12B−/− septic mice.

markedly prevented sepsis-induced increases in VACM-1
(Figure 6D) and ICAM-1 (Figure 6E) levels in the myocardium.
We also analyzed the effect of delivery of exosomal miR126 on sepsis-induced accumulation of immune cell in the
myocardium. As shown in Figure 6F, delivery of exosomal
miR-126 significantly decreased sepsis-induced accumulation
of neutrophil (Figure 6G) and macrophage (Figure 6H)
in the myocardium from HSPA12B−/− septic mice. The
data clearly suggest that decreased miR-126 levels could be
responsible for increased expression of adhesion molecules
and immune cell accumulation in the myocardium in
HSPA12B−/− septic mice.

HSPA12B−/− Septic Exosomes Enhance
the Expression of Adhesion Molecules
on ECs

Delivery of Exosomal miR-126 Improved
Cardiac Function in HSPA12B−/− Septic
Mice

To investigate the role of HSPA12B−/− septic exosomes in
adhesion molecule expression on ECs, we collected blood and
isolated serum exosomes from WT and HSPA12B−/− mice. We
then treated ECs with the isolated exosomes and examined the
levels of adhesion molecules. Figure 5B shows exosome markers
(CD63 and CD81) in the isolated exosomes. Figures 5C,D
shows that treatment of ECs with WT septic exosomes markedly
increased 87.2% VCAM-1C and 157.3% ICAM-1D levels, when
compared with the WT sham exosome-treated group. However,
treatment of ECs with HSPA12B−/− septic exosomes resulted
in greater levels of VCAM-1 and ICAM-1, when compared
with WT septic exosome treatment. The levels of VCAM-1
and ICAM-1 in the HSPA12B−/− septic exosomes group were
75.1 and 78.9% greater than in WT septic exosome-treated
cells. The data suggest that lower levels of miR-126 in the
exosomes from HSPA12B−/− septic mice may be responsible
for increased adhesion molecule expression in the myocardium
during polymicrobial sepsis.

We then examined whether suppression of adhesion molecule
expression and reduced accumulation of immune cells in
the myocardium by exosomal miR-126 will improve cardiac
function in HSPA12B−/− septic mice. Figures 6I,J show
that delivery of exosomal miR-126 into the myocardium
of HSPA12B−/− septic mice significantly increased the
values of EF% (47.8%) and %FS (61.2%) respectively, when
compared with the exosomal miR-control group. The data
demonstrated that miR-126 plays an important role in cardiac
function by suppressing adhesion molecule expression during
polymicrobial sepsis.

DISCUSSION
The present study has shown that EC-specific HSAP12B
exerts a protective role in polymicrobial sepsis–induced
cardiomyopathy. There are several important findings in
the present study. First, deficiency of endothelial-specific
HSPA12B (HSPA12B−/− ) results in severe cardiac dysfunction
and poor survival outcome following polymicrobial sepsis,
suggesting that endothelial HSP12B serves a protective role
in cardiac function in sepsis. Second, endothelial HSPA12B
deficiency promotes the increased expression of adhesion
molecules and leads to accumulation of immune cells in the
myocardium. This indicates that HSPA12B is involved in
controlling adhesion molecule expression and immune cell
infiltration into the myocardium following CLP sepsis. Third,
the serum exosomes isolated from HSPA12B−/− septic mice
contain lower levels of miR-126 when compared with the
exosomes from WT septic mice. MicroRNA-126 specifically
targets adhesion molecules (20). Therefore, it is possible that
lower levels of miR-126 may be responsible for increased
adhesion molecule expression and accumulation of immune
cells in the myocardium. Finally, we loaded miR-126 onto
exosomes derived from HSPA12B−/− BMSCs, delivered into
the myocardium of HSPA12B−/− septic mice, and observed
that transfection of miR-126 carried by exosomes significantly
improves cardiac function of HSPA12B−/− septic mice by
suppressing the expression of adhesion molecules and decreasing
the infiltration of inflammatory cells into the myocardium. The

Delivery of miR-126 Carried by
Exosomes Suppressed Adhesion
Molecule Expression in the Myocardium
From HSPA12B−/− Septic Mice
To further investigate the role of exosomal miR-126 in the
regulation of adhesion molecule expression, we isolated BMSCs
from HSPA12B−/− mice, transfected BMSCs with miR-126
mimics or miR-control mimics, and isolated exosomes from
cultured medium. Figure 6A shows that miR-126 levels in
the exosomes were significantly greater than in the exosomes
loaded with miR-control. We delivered the exosomal miR126 or exosomal miR-control into the myocardium through
the right carotid artery (27, 29) immediately after induction
of CLP in HSPA12B−/− mice. Twenty-four hours after
delivery, we collected blood and measured serum levels of
miR-126 levels by qPCR. Figure 6B shows that delivery of
exosomal miR-126 markedly increased the serum miR-126
levels (178%) in HSPA12B−/− septic mice compared with
delivery of exosomal miR-control. Immunostaining shows
that delivery of exosomal miR-126 prevented sepsis-increased
expression of VCAM-1 and ICAM-1 (Figure 6C). Western
blot analysis shows that exosomal miR-126 transfection
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FIGURE 6 | MicroRNA-126 carried by exosomes derived from bone marrow stromal cells suppressed adhesion molecule expression in the myocardium of
HSPA12B−/− septic mice. Bone marrow stromal cells (BMSCs) were isolated from HSPA12B−/− mice and transfected with 40 nmol/L scrambled miR-control or
miR-126 mimics at the fourth to seventh generation. Twenty-four hours after transfection, exosomes were isolated from supernatants. (A) The levels of miR-126 in
exosomes were examined qPCR. (B) HSPA12B−/− mice were transfected with exosomes loaded with miR-126 mimic or scrambled miR-control through the right
carotid artery immediately before induction of CLP sepsis. Serum miR-126 levels were examined by qPCR 6 h after CLP. (C) VCAM-1 and ICAM1 expressions in the
heart tissues were examined by immunohistochemistry staining with anti–VCAM-1 and anti–ICAM-1 antibodies. (D,E) Western blot analysis of VCAM-1 and ICAM1
levels in the myocardium of HSP12B−/− septic mice (n = 6–9/group). (F) The accumulation of neutrophils and macrophages in the myocardium was examined by
immunohistochemistry with antineutrophil elastase antibody and antimacrophage antibody F4/80. (G,H) miR-126 carried by exosomes decreased the numbers of
neutrophils (G) and macrophages (H) in the myocardium of HSPA12B−/− septic mice. (I,J) miR-126 carried by exosomes improves cardiac function (EF %, FS %)
measured by echocardiography. n = 6–9/group for Western blot and n = 3/group for immunohistochemistry. *P < 0.05 compared with indicated groups. The
immunohistochemistry staining was examined with bright field microscope (40×).
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that treatment of ECs with exosomes that were isolated
from HSPA12B−/− septic mice significantly increased the
expression of VCAM-1 and ICAM1, when compared with
WT septic exosomes. Our observations suggest that exosomes
isolated from septic mice play a critical role in mediating EC
dysfunction during sepsis.
At present, we do not understand which cells released
exosomes into the serum in response to polymicrobial
sepsis/shock. We also do not understand which compositions
in the septic exosomes will be responsible for causing EC
dysfunction. Interestingly, we observed that the levels of miR126 in HSPA12B−/− septic exosomes were significantly lower
than in WT septic exosomes. MicroRNA-126 is predominately
expressed in ECs (18), targets adhesion molecules (20),
and regulates angiogenesis (19). Lower levels of miR-126 in
the exosomes may be responsible for the higher levels of
myocardial adhesion molecules of HSPA12B−/− septic mice.
To evaluate our hypothesis, we treated ECs with exosomes
that were isolated from septic mice and observed that the
levels of adhesion molecules in HSPA12B−/− septic exosometreated ECs were significantly greater than in the effect
of WT septic exosomes. To confirm our observation, we
transfected ECs with miR-126 mimics before the cells were
treated with LPS and observed that transfection miR-126
markedly suppresses LPS-induced increases in the expression of
adhesion molecules.
Our in vitro data indicate that suppression of adhesion
molecule expression by miR-126 mimics may decrease the
infiltration of inflammatory cells into the myocardium and
result in attenuation of cardiac function in vivo following
polymicrobial sepsis. To test this hypothesis, we isolated
BMSCs from HSPA12B−/− mice, transfected BMSCs with
miR-126 mimics and isolated exosomes derived from
BMSCs. We then delivered miR-126 carried by exosomes
into the myocardium immediately after induction of
polymicrobial sepsis. We observed that delivery of miR126 carried by exosomes significantly improved cardiac
function in HSPA12B−/− septic mice. Importantly, delivery of
exosomes loaded with miR-126 attenuated sepsis-induced
expression of adhesion molecules and accumulation of
macrophages and neutrophils in the myocardium of
HSPA12B−/− mice. At the moment, we do not understand
the mechanisms by which endothelial-specific deficiency
of HSPA12B results in lower levels of miR-126 in serum
exosomes. However, our data suggest that targeting adhesion
molecules is an important approach for maintenance
of EC function and attenuation of inflammatory cell
infiltration in the myocardium during polymicrobial sepsis.
Exosomes loaded with miR-126 could be a novel approach
for this purpose.

data suggest that endothelial miR-126 plays an important role
in HSPA12B regulation of adhesion molecule expression during
polymicrobial sepsis.
It is well known that EC dysfunction contributes to
the pathophysiology of sepsis/septic shock and multiple
organ dysfunction (34). Biomarkers of EC dysfunction
have been concentrated on ICAMs. Increased expression
of adhesion molecules, such as ICAM-1 and VCAM-1, has
been shown to recruit neutrophils and macrophages into
the myocardium, leading to cardiac dysfunction in sepsis
(35, 36). Activated macrophages also release chemokines
to attract neutrophils into the myocardium (35). We have
previously reported that polymicrobial sepsis (22) and
endotoxemia (13) significantly increased the expression of
adhesion molecules, resulting in accumulation of neutrophils
and macrophages in the myocardium. Therefore, suppression
of adhesion molecule expression could be an important
approach for the attenuation of sepsis-induced cardiomyopathy.
Indeed, we observed in our previous studies that transgenic
mice with EC-specific expression of HSPA12B show a
significant attenuation of endotoxin-increased adhesion
molecule expression and cardiac dysfunction through
activation of PI3K/Akt signaling (13). However, the precise
mechanisms by which HSPA12B is required for EC function
are still unsolved.
We observed in the present study that HSPA12B−/− septic
mice exhibit higher levels of adhesion molecules and greater
immune cell accumulation in the myocardium than in WT
septic mice. Our observation is consistent with previous
studies showing HSPA12B is essential for EC functioning
during sepsis/septic shock (13). Increased expression of ICAM1 and VCAM-1 facilities the recruitment of macrophages and
neutrophils into the myocardium, leading to inflammatory
response in sepsis (35, 36). We observed that myocardial
NF-κB binding activity and serum inflammatory cytokine
levels, such as TNFα and IL-6, in HSPA12B−/− septic
mice were markedly greater than in WT septic mice. This
suggests that endothelial HSPA12B may play a role in
not only regulating adhesion molecule expression but also
controlling NF-κB mediated inflammatory cytokine production
in polymicrobial sepsis.
To investigate how EC deficiency of HSPA12B increased
adhesion molecule expression and the accumulation of
immune cells in the myocardium following polymicrobial
sepsis, we examined the effects of serum exosomes isolated
from experimental mice on adhesion molecule expression
in ECs in vitro. Exosomes are membranous nanovesicles
(30–100 nm), which arise inside many cells from endosomal
compartments called multivesicular bodies (37). Recent
evidence demonstrated that exosomes play a critical role
in cell-to-cell communication and serve as a novel vehicle
for transferring proteins and/or miRs (37–39) from one
cell to another through membrane fusion with the target
cells, by binding with specific receptors at the cell surface
of target cells, or endocytotic internalization. Exosomes
are also shown to play a key role in host immunity to
pathogens during infection (40). Interestingly, we found
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